Clinical trial • Phase I • Oncology

JNJ-86974680 for Advanced non-small cell lung cancer

Phase I trial of JNJ-86974680 for Advanced non-small cell lung cancer. 76 participants.

Overview

Trial Therapeutic Area
Oncology
Trial Disease
Advanced non-small cell lung cancer
Trial Stage
Phase I
Drug Modality
Small molecule|Monoclonal antibody

Key dates

Initial CTIS Submission Date
12-09-2023
First CTIS Authorization Date
15-01-2024

Trial design

Phase I trial across 5 sites in Germany, Spain.

Target Sample Size
76

Recruitment

Planned Sample Size
76
Recruitment Window Months
25

Geography

Total Number Of Sites
5
Total Number Of Participants
50

Germany

Earliest CTIS Part Ii Submission Date
28-11-2023
Latest Decision Or Authorization Date
02-03-2026
Processing Time Days
825
Number Of Sites
1
Number Of Participants
15

Sites

Site Name
Justus-Liebig-Universitaet Giessen
Department Name
Medizinische Klinik IV Organonkologie
Principal Investigator Name
Thomas Wehler
Principal Investigator Email
thomas.wehler@innere.med.uni-giessen.de
Contact Person Name
Thomas Wehler

Spain

Earliest CTIS Part Ii Submission Date
04-12-2023
Latest Decision Or Authorization Date
26-02-2026
Processing Time Days
815
Number Of Sites
4
Number Of Participants
35

Sites

Site Name
Instituto Oncologico Dr. Rosell S.L.
Department Name
Medical Oncology
Principal Investigator Name
Andrés Aguilar
Principal Investigator Email
aaguilar@oncorosell.com
Contact Person Name
Andrés Aguilar
Contact Person Email
aaguilar@oncorosell.com
Site Name
Hospital Universitario Y Politecnico La Fe
Department Name
Medical Oncology
Principal Investigator Name
Oscar Jose Juan Vidal
Principal Investigator Email
juan_osc@gva.es
Contact Person Name
Oscar Jose Juan Vidal
Contact Person Email
juan_osc@gva.es
Site Name
Hospital Universitario 12 De Octubre
Department Name
Medical Oncology
Principal Investigator Name
Santiago Ponce
Principal Investigator Email
santiago.ponce@oncosur.org
Contact Person Name
Santiago Ponce
Contact Person Email
santiago.ponce@oncosur.org
Site Name
Hospital Universitari Vall D Hebron
Department Name
Medical Oncology
Principal Investigator Name
Enriqueta Felip
Principal Investigator Email
efelip@vhio.net
Contact Person Name
Enriqueta Felip
Contact Person Email
efelip@vhio.net

Sponsor

Primary sponsor

Full Name
Johnson And Johnson Enterprise Innovation Inc.
Organisation Type
Pharmaceutical company
Country Of Registered Address
United States

Investigational products

Investigational Product Name
JNJ-86974680
Modality
Small molecule
Investigational Product Name
cetrelimab
Modality
Monoclonal antibody
Combination Treatment
Yes

Related trials

Other published trials that may interest you.